job losses

News

Editas axes two-thirds of its staff, including its CMO

Editas Medicine ends development of its gene-editing therapy for thalassaemia and sickle cell, shedding 65% of staff and narrowing its R&D focus.

News

Mulvany hits the reset button at BenevolentAI

The shape of BenevolentAI following the return of co-founder Ken Mulvany has started to crystallise and could see the company return to private hands.

News

Alligator slashes workforce and pares down its pipeline

Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce.

News

Medigene axes staff and refocuses its TCR pipeline

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline

News

23andMe ends drug development and slashes staff

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses.

News

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

Bayer’s first-quarter results update shows that its workforce has declined by more than 1,500 full-time equivalent (FTE) employees since the end of last year, suggesting r

Editas axes two-thirds of its staff, including its CMO

Mulvany hits the reset button at BenevolentAI

Alligator slashes workforce and pares down its pipeline

Medigene axes staff and refocuses its TCR pipeline

23andMe ends drug development and slashes staff

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

EMA seeks input on virtual alternatives to animal testing

Using AI-driven synthetic personas to take your insights fur...

job losses

Editor's Picks